首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Annals of pharmacotherapy

缩写:ANN PHARMACOTHER

ISSN:1060-0280

e-ISSN:1542-6270

IF/分区:2.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引4240
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lindsay P Deloney,Melanie Smith Condeni,Cassandra Carter et al. Lindsay P Deloney et al.
Background: Rib fractures account for more than one-third of blunt thoracic injuries and are associated with serious complications. Use of nonopioid adjunctive agents such as methocarbamol for pain control has increased c...
Lara M Groetzinger,Aaron T Hutchins,Ryan M Rivosecchi Lara M Groetzinger
Background: Recent medication shortages of the neuromuscular blocking agent (NMBA) cisatracurium have forced the prescribing of aminosteroidal agents such as rocuronium. There are limited data on the use and dosing of con...
Jacob Dresser,Kyle John Wilby Jacob Dresser
Objective: To compare the incidence and types of adverse effects between 3 recommended treatment options for gonorrhea and to compare the incidence of injection site pain between single-dose intramuscular ceftriaxone and ...
Anthony J Gentene,Allison M Bell,Alicia Pence et al. Anthony J Gentene et al.
Background: Direct-acting antivirals (DAAs) for treatment of hepatitis C virus (HCV) have resulted in great success through high attainment of sustained virologic response (SVR). Risk factors for DAA treatment failure are...
Douglas Slain Douglas Slain
Objective: To review the pharmacology, clinical trial data, and clinical implications for the intravenous formulation of zanamivir. Data sources: ...
Alexander H Flannery,Gary D Owen,Angel Coz et al. Alexander H Flannery et al.
Background: While albumin has not been shown to reduce mortality in sepsis and septic shock, a tertiary analysis of a large trial suggested that it may reduce the duration of vasopressor use in septic shock. ...
Kayla Rena Joyner,Kelsey Woods Morgan Kayla Rena Joyner
Objective: To review the efficacy, safety, and cost of 3 newly approved agents-ubrogepant, lasmiditan, and rimegepant-representing 2 therapeutic classes, calcitonin gene-related peptide (CGRP) receptor antagonist and sero...